T Cell Activation, PSMA Seroconversion and Increased Th17 Rates are Associated with Favorable Clinical Outcome in Prostate Cancer Patients Treated with Prostate GVAX and Anti-CTLA4 Immunotherapy

S.J.A.M. Santegoets; A.J.M. van den Eertwegh; A.G.M. Stam; R.J. Scheper; S.M. Lougheed; P.E. Scholten; B.M.E. von Blomberg; H. Gall; K. Jooss; N. Sacks; T. Harding; K. Hege; I. Lowy; W.R. Gerritsen; T.D. de Gruijl

T Cell Activation, PSMA Seroconversion and Increased Th17 Rates are Associated with Favorable Clinical Outcome in Prostate Cancer Patients Treated with Prostate GVAX and Anti-CTLA4 Immunotherapy

S.J.A.M. Santegoets, A.J.M. van den Eertwegh, A.G.M. Stam, R.J. Scheper, S.M. Lougheed, P.E. Scholten, B.M.E. von Blomberg, H. Gall, K. Jooss, N. Sacks, T. Harding, K. Hege, I. Lowy, W.R. Gerritsen, T.D. de Gruijl

Research output: Contribution to journal › Meeting Abstract › Other research output

Original language	Undefined/Unknown
Pages (from-to)	918-919
Journal	Journal of Immunotherapy
Volume	33
Issue number	8
Publication status	Published - 2010

Cite this

Santegoets, S. J. A. M., van den Eertwegh, A. J. M., Stam, A. G. M., Scheper, R. J., Lougheed, S. M., Scholten, P. E., von Blomberg, B. M. E., Gall, H., Jooss, K., Sacks, N., Harding, T., Hege, K., Lowy, I., Gerritsen, W. R., & de Gruijl, T. D. (2010). T Cell Activation, PSMA Seroconversion and Increased Th17 Rates are Associated with Favorable Clinical Outcome in Prostate Cancer Patients Treated with Prostate GVAX and Anti-CTLA4 Immunotherapy. Journal of Immunotherapy, 33(8), 918-919.

@article{cc1ead8456124269b3eac4eed061f38e,

title = "T Cell Activation, PSMA Seroconversion and Increased Th17 Rates are Associated with Favorable Clinical Outcome in Prostate Cancer Patients Treated with Prostate GVAX and Anti-CTLA4 Immunotherapy",

author = "S.J.A.M. Santegoets and {van den Eertwegh}, A.J.M. and A.G.M. Stam and R.J. Scheper and S.M. Lougheed and P.E. Scholten and {von Blomberg}, B.M.E. and H. Gall and K. Jooss and N. Sacks and T. Harding and K. Hege and I. Lowy and W.R. Gerritsen and {de Gruijl}, T.D.",

year = "2010",

language = "Undefined/Unknown",

volume = "33",

pages = "918--919",

journal = "Journal of Immunotherapy",

issn = "1524-9557",

publisher = "Lippincott Williams and Wilkins",

number = "8",

}

Santegoets, SJAM, van den Eertwegh, AJM , Stam, AGM , Scheper, RJ , Lougheed, SM, Scholten, PE, von Blomberg, BME, Gall, H, Jooss, K, Sacks, N, Harding, T, Hege, K, Lowy, I, Gerritsen, WR & de Gruijl, TD 2010, 'T Cell Activation, PSMA Seroconversion and Increased Th17 Rates are Associated with Favorable Clinical Outcome in Prostate Cancer Patients Treated with Prostate GVAX and Anti-CTLA4 Immunotherapy', Journal of Immunotherapy, vol. 33, no. 8, pp. 918-919.

T Cell Activation, PSMA Seroconversion and Increased Th17 Rates are Associated with Favorable Clinical Outcome in Prostate Cancer Patients Treated with Prostate GVAX and Anti-CTLA4 Immunotherapy. / Santegoets, S.J.A.M.; van den Eertwegh, A.J.M.; Stam, A.G.M. et al.
In: Journal of Immunotherapy, Vol. 33, No. 8, 2010, p. 918-919.

Research output: Contribution to journal › Meeting Abstract › Other research output

TY - JOUR

T1 - T Cell Activation, PSMA Seroconversion and Increased Th17 Rates are Associated with Favorable Clinical Outcome in Prostate Cancer Patients Treated with Prostate GVAX and Anti-CTLA4 Immunotherapy

AU - Santegoets, S.J.A.M.

AU - van den Eertwegh, A.J.M.

AU - Stam, A.G.M.

AU - Scheper, R.J.

AU - Lougheed, S.M.

AU - Scholten, P.E.

AU - von Blomberg, B.M.E.

AU - Gall, H.

AU - Jooss, K.

AU - Sacks, N.

AU - Harding, T.

AU - Hege, K.

AU - Lowy, I.

AU - Gerritsen, W.R.

AU - de Gruijl, T.D.

PY - 2010

Y1 - 2010

M3 - Meeting Abstract

SN - 1524-9557

VL - 33

SP - 918

EP - 919

JO - Journal of Immunotherapy

JF - Journal of Immunotherapy

IS - 8

ER -